IOL implantation improves sleep quality

Article

Removal of a cataract and implantation of an intraocular lens (IOL) improves overall sleep quality and sleep latency, according to a study published online before print.

Removal of a cataract and implantation of an intraocular lens (IOL) improves overall sleep quality and sleep latency, according to a study published online before print in Investigative Ophthalmology and Visual Science.

Researchers in the UK were seeking information on how the melanopsin-based photosensitive retinal ganglion cells (pRGC's) regulate sleep/wake timing in patients who have cataracts. They used the Pittsburgh Sleep Quality Index (PSQI) to assess quality of sleep in 961 patients undergoing cataract surgery. The patients received either an ultraviolet blocking (UVB) clear IOL (498 patients) or a blue-filtering (BF) IOL (463 patients). The patients completed the PSQI questionnaires 1 month preoperatively and 1, 6 (UVB-IOL patients only) and 12 months postoperatively.

The researchers found that cataract removal - regardless of the type of IOL implanted - improved overall sleep quality significantly 1 month postoperatively. Sleep latency (the shortening in time to fall asleep) also improved, and the improvement was sustained at 6 and 12 months postoperatively.

"The key finding of this study is the sustained improvement in sleep latency after surgery irrespective of IOL type implanted. This result highlights a significant benefit of cataract surgery in addition to improvement in visual acuity," the researchers wrote.

To read the full study, visit the journal's website.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
Omer Trivizki, MD, MBA, a retina specialist from Tel Aviv Medical Center, speaks about VOY-101, a Novel, Complement-Modulating Gene Therapy for Geographic Atrophy at the American Society of Retina Specialists (ASRS) Annual Meeting
João Pedro Marques, MD, MSc, PhD discusses a retrospective study of 800 patients with inherited retinal diseases during the American Society of Retina Specialists (ASRS) annual meeting
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
© 2025 MJH Life Sciences

All rights reserved.